DLL3 is an atypical Notch pathway ligand that, in contrast to canonical Notch ligands, is predominantly localized to the Golgi in normal cells but exhibits aberrant cell surface expression in neuroendocrine tumor cells, where its functional role on the surface is an area of active research. This evidence concerns the gene DLL3 and neuroendocrine neoplasm.